209 related articles for article (PubMed ID: 15537361)
1. Design, synthesis, and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain.
Teodori E; Baldi E; Dei S; Gualtieri F; Romanelli MN; Scapecchi S; Bellucci C; Ghelardini C; Matucci R
J Med Chem; 2004 Nov; 47(24):6070-81. PubMed ID: 15537361
[TBL] [Abstract][Full Text] [Related]
2. Scaffold-based design and synthesis of potent N-type calcium channel blockers.
Zamponi GW; Feng ZP; Zhang L; Pajouhesh H; Ding Y; Belardetti F; Pajouhesh H; Dolphin D; Mitscher LA; Snutch TP
Bioorg Med Chem Lett; 2009 Nov; 19(22):6467-72. PubMed ID: 19815411
[TBL] [Abstract][Full Text] [Related]
3. Analgesic activity of ZC88, a novel N-type voltage-dependent calcium channel blocker, and its modulation of morphine analgesia, tolerance and dependence.
Meng G; Wu N; Zhang C; Su RB; Lu XQ; Liu Y; Yun LH; Zheng JQ; Li J
Eur J Pharmacol; 2008 May; 586(1-3):130-8. PubMed ID: 18374913
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships of diphenylpiperazine N-type calcium channel inhibitors.
Pajouhesh H; Feng ZP; Ding Y; Zhang L; Pajouhesh H; Morrison JL; Belardetti F; Tringham E; Simonson E; Vanderah TW; Porreca F; Zamponi GW; Mitscher LA; Snutch TP
Bioorg Med Chem Lett; 2010 Feb; 20(4):1378-83. PubMed ID: 20117000
[TBL] [Abstract][Full Text] [Related]
5. Discovery, structure-activity relationship study, and oral analgesic efficacy of cyproheptadine derivatives possessing N-type calcium channel inhibitory activity.
Yamamoto T; Niwa S; Iwayama S; Koganei H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Yamamoto H; Shoji M
Bioorg Med Chem; 2006 Aug; 14(15):5333-9. PubMed ID: 16616501
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and SAR of novel 2-arylthiazolidinones as selective analgesic N-type calcium channel blockers.
Knutsen LJ; Hobbs CJ; Earnshaw CG; Fiumana A; Gilbert J; Mellor SL; Radford F; Smith NJ; Birch PJ; Russell Burley J; Ward SD; James IF
Bioorg Med Chem Lett; 2007 Feb; 17(3):662-7. PubMed ID: 17134896
[TBL] [Abstract][Full Text] [Related]
7. Discovery and evaluation of selective N-type calcium channel blockers: 6-unsubstituted-1,4-dihydropyridine-5-carboxylic acid derivatives.
Yamamoto T; Niwa S; Tokumasu M; Onishi T; Ohno S; Hagihara M; Koganei H; Fujita S; Takeda T; Saitou Y; Iwayama S; Takahara A; Iwata S; Shoji M
Bioorg Med Chem Lett; 2012 Jun; 22(11):3639-42. PubMed ID: 22560585
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship study of 1,4-dihydropyridine derivatives blocking N-type calcium channels.
Yamamoto T; Niwa S; Ohno S; Onishi T; Matsueda H; Koganei H; Uneyama H; Fujita S; Takeda T; Kito M; Ono Y; Saitou Y; Takahara A; Iwata S; Shoji M
Bioorg Med Chem Lett; 2006 Feb; 16(4):798-802. PubMed ID: 16309909
[TBL] [Abstract][Full Text] [Related]
9. Pyridazinoquinolinetriones as NMDA glycine-site antagonists with oral antinociceptive activity in a model of neuropathic pain.
Bare TM; Brown DG; Horchler CL; Murphy M; Urbanek RA; Alford V; Barlaam C; Dyroff MC; Empfield JB; Forst JM; Herzog KJ; Keith RA; Kirschner AS; Lee CM; Lewis J; McLaren FM; Neilson KL; Steelman GB; Trivedi S; Vacek EP; Xiao W
J Med Chem; 2007 Jun; 50(13):3113-31. PubMed ID: 17542571
[TBL] [Abstract][Full Text] [Related]
10. T-type calcium channel blockers: spiro-piperidine azetidines and azetidinones-optimization, design and synthesis.
Smith EM; Sorota S; Kim HM; McKittrick BA; Nechuta TL; Bennett C; Knutson C; Burnett DA; Kieselgof J; Tan Z; Rindgen D; Bridal T; Zhou X; Jia YP; Dong Z; Mullins D; Zhang X; Priestley T; Correll CC; Tulshian D; Czarniecki M; Greenlee WJ
Bioorg Med Chem Lett; 2010 Aug; 20(15):4602-6. PubMed ID: 20580233
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and SAR of 4-aminocyclopentapyrrolidines as N-type Ca²⁺ channel blockers with analgesic activity.
Beebe X; Darczak D; Henry RF; Vortherms T; Janis R; Namovic M; Donnelly-Roberts D; Kage KL; Surowy C; Milicic I; Niforatos W; Swensen A; Marsh KC; Wetter JM; Franklin P; Baker S; Zhong C; Simler G; Gomez E; Boyce-Rustay JM; Zhu CZ; Stewart AO; Jarvis MF; Scott VE
Bioorg Med Chem; 2012 Jul; 20(13):4128-39. PubMed ID: 22626552
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies on N'-aryl carbohydrazide P2X7 antagonists.
Nelson DW; Sarris K; Kalvin DM; Namovic MT; Grayson G; Donnelly-Roberts DL; Harris R; Honore P; Jarvis MF; Faltynek CR; Carroll WA
J Med Chem; 2008 May; 51(10):3030-4. PubMed ID: 18438986
[TBL] [Abstract][Full Text] [Related]
13. Neuronal N-type calcium channel blockers: a series of 4-piperidinylaniline analogs with analgesic activity.
Hu LY; Ryder TR; Rafferty MF; Siebers KM; Malone T; Chatterjee A; Feng MR; Lotarski SM; Rock DM; Stoehr SJ; Taylor CP; Weber ML; Miljanich GP; Millerman E; Szoke BG
Drug Des Discov; 2000; 17(1):85-93. PubMed ID: 10928451
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity study and analgesic efficacy of amino acid derivatives as N-type calcium channel blockers.
Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M
Bioorg Med Chem Lett; 2001 Aug; 11(16):2067-70. PubMed ID: 11514140
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N,N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channels.
Maillard MC; Perlman ME; Amitay O; Baxter D; Berlove D; Connaughton S; Fischer JB; Guo JQ; Hu LY; McBurney RN; Nagy PI; Subbarao K; Yost EA; Zhang L; Durant GJ
J Med Chem; 1998 Jul; 41(16):3048-61. PubMed ID: 9685245
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonist.
Shipe WD; Barrow JC; Yang ZQ; Lindsley CW; Yang FV; Schlegel KA; Shu Y; Rittle KE; Bock MG; Hartman GD; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Uebele VN; Nuss CE; Connolly TM; Doran SM; Fox SV; Kraus RL; Marino MJ; Graufelds VK; Vargas HM; Bunting PB; Hasbun-Manning M; Evans RM; Koblan KS; Renger JJ
J Med Chem; 2008 Jul; 51(13):3692-5. PubMed ID: 18540666
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and SAR of 4-aminocyclopentapyrrolidines as orally active N-type calcium channel inhibitors for inflammatory and neuropathic pain.
Beebe X; Yeung CM; Darczak D; Shekhar S; Vortherms TA; Miller L; Milicic I; Swensen AM; Zhu CZ; Banfor P; Wetter JM; Marsh KC; Jarvis MF; Scott VE; Schrimpf MR; Lee CH
Bioorg Med Chem Lett; 2013 Sep; 23(17):4857-61. PubMed ID: 23876987
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of nonpeptide mimetics of omega-conotoxin GVIA.
Baell JB; Duggan PJ; Forsyth SA; Lewis RJ; Lok YP; Schroeder CI
Bioorg Med Chem; 2004 Aug; 12(15):4025-37. PubMed ID: 15246080
[TBL] [Abstract][Full Text] [Related]
20. Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives.
Jo MN; Seo HJ; Kim Y; Seo SH; Rhim H; Cho YS; Cha JH; Koh HY; Choo H; Pae AN
Bioorg Med Chem; 2007 Jan; 15(1):365-73. PubMed ID: 17035033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
